Back to today’s briefing

Story perspectives

Breakthrough Tear-Test Could Revolutionize Glioblastoma Diagnosis

9/29/2025

49 10

Summary

Story summary

A study at the Manchester Cancer Research Centre tests tear-fluid biomarkers to detect glioblastoma, aiming for earlier diagnoses.
Alex Davies, a father with an incurable brain tumor, participates to help validate the tear-protein classifier.
The project has received £500,000 in funding from Stand Up To Cancer.
If proven accurate, the test could be used in GP surgeries for timely diagnoses.

1 of 1

Story summary

A study at the Manchester Cancer Research Centre tests tear-fluid biomarkers to detect glioblastoma, aiming for earlier diagnoses.
Alex Davies, a father with an incurable brain tumor, participates to help validate the tear-protein classifier.
The project has received £500,000 in funding from Stand Up To Cancer.
If proven accurate, the test could be used in GP surgeries for timely diagnoses.